Bayesian analysis and classification of two enzyme‐linked immunosorbent assay tests without a gold standard

Reconciling two quantitative enzyme‐linked immunosorbent assay tests for an antibody to an RNA virus, in a situation without a gold standard and where false negatives may occur, is the motivation for this work. False negatives occur when access of the antibody to the binding site is blocked. On the basis of the mechanism of the assay, a mixture of four bivariate normal distributions is proposed with the mixture probabilities depending on a two‐stage latent variable model including the prevalence of the antibody in the population and the probabilities of blocking on each test. There is prior information on the prevalence of the antibody, and also on the probability of false negatives, and so a Bayesian analysis is used. The dependence between the two tests is modeled to be consistent with the biological mechanism. Bayesian decision theory is utilized for classification.The proposed method is applied to the motivating data set to classify the data into two groups: those with and those without the antibody. Simulation studies describe the properties of the estimation and the classification. Sensitivity to the choice of the prior distribution is also addressed by simulation. The same model with two levels of latent variables is applicable in other testing procedures such as quantitative polymerase chain reaction tests, where false negatives occur when there is a mutation in the primer sequence. Copyright © 2013 John Wiley & Sons, Ltd.

[1]  D. Montefiori,et al.  GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 Isolates , 2010, The Journal of Immunology.

[2]  Ronald Christensen,et al.  Bayesian Ideas and Data Analysis: An Introduction for Scientists and Statisticians , 2010 .

[3]  R. Gascoyne,et al.  GBV‐C/hepatitis G virus infection and non‐Hodgkin lymphoma: a case control study , 2010, International journal of cancer.

[4]  J. McLinden,et al.  Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells1 , 2009, The Journal of Immunology.

[5]  J. Stapleton,et al.  GB virus type C interactions with HIV: the role of envelope glycoproteins , 2009, Journal of viral hepatitis.

[6]  K. Chaloner,et al.  GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy , 2009, AIDS.

[7]  Bruce W. Turnbull,et al.  Nonparametric estimation of ROC curves based on Bayesian models when the true disease state is unknown , 2007 .

[8]  M. Houghton,et al.  Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding , 2006, Journal of Virology.

[9]  Wesley O. Johnson,et al.  Bayesian inferences for receiver operating characteristic curves in the absence of a gold standard , 2006 .

[10]  K. Chaloner,et al.  Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.

[11]  M. Plummer,et al.  CODA: convergence diagnosis and output analysis for MCMC , 2006 .

[12]  P. Qiu The Statistical Evaluation of Medical Tests for Classification and Prediction , 2005 .

[13]  Xiao-Hua Zhou,et al.  Nonparametric Estimation of ROC Curves in the Absence of a Gold Standard , 2005, Biometrics.

[14]  J. Slim,et al.  Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1 , 2005, Retrovirology.

[15]  Morris H. DeGroot,et al.  Optimal Statistical Decisions: DeGroot/Statistical Decisions WCL , 2005 .

[16]  Andrew Gelman,et al.  R2WinBUGS: A Package for Running WinBUGS from R , 2005 .

[17]  Xiao-Hua Zhou,et al.  NONPARAMETRIC ESTIMATION OF COMPONENT DISTRIBUTIONS IN A MULTIVARIATE MIXTURE , 2003 .

[18]  B. Craig,et al.  Estimating disease prevalence in the absence of a gold standard , 2002, Statistics in medicine.

[19]  S. Nielsen,et al.  Maximum-likelihood estimation of sensitivity and specificity of ELISAs and faecal culture for diagnosis of paratuberculosis. , 2002, Preventive veterinary medicine.

[20]  M. Manns,et al.  Infection with GB virus C and reduced mortality among HIV-infected patients. , 2001, The New England journal of medicine.

[21]  L. Joseph,et al.  Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests , 2001, Biometrics.

[22]  Andrew Thomas,et al.  WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..

[23]  J. Lang,et al.  High Prevalence of GB Virus C/Hepatitis G Virus RNA and Antibodies in Patients Infected with Human Immunodeficiency Virus Type 1 , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[24]  W O Johnson,et al.  Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown. , 2000, Preventive veterinary medicine.

[25]  F. Lucht,et al.  Prevalence of GBV‐C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure , 1999, Journal of medical virology.

[26]  D. Ouzan,et al.  High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV-infected patients. , 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  S. Hui,et al.  Evaluation of diagnostic tests without gold standards , 1998, Statistical methods in medical research.

[28]  M. Manns,et al.  GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? , 1998, The Journal of infectious diseases.

[29]  I Yang,et al.  Latent variable modeling of diagnostic accuracy. , 1997, Biometrics.

[30]  K. Stark,et al.  Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.

[31]  M. Tan,et al.  Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. , 1996, Biometrics.

[32]  L. Joseph,et al.  Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. , 1995, American journal of epidemiology.

[33]  Jun S. Liu,et al.  Linear Combinations of Multiple Diagnostic Markers , 1993 .

[34]  Adrian E. Raftery,et al.  [Practical Markov Chain Monte Carlo]: Comment: One Long Run with Diagnostics: Implementation Strategies for Markov Chain Monte Carlo , 1992 .

[35]  M. Bronskill,et al.  Receiver Operator characteristic (ROC) Analysis without Truth , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.

[36]  S D Walter,et al.  Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. , 1988, Journal of clinical epidemiology.

[37]  P M Vacek,et al.  The effect of conditional dependence on the evaluation of diagnostic tests. , 1985, Biometrics.

[38]  A. Azzalini A class of distributions which includes the normal ones , 1985 .

[39]  Philip Heidelberger,et al.  Simulation Run Length Control in the Presence of an Initial Transient , 1983, Oper. Res..

[40]  S. Walter,et al.  Estimating the error rates of diagnostic tests. , 1980, Biometrics.

[41]  M. Degroot Optimal Statistical Decisions , 1970 .